Active site specificity of plasmepsin II

Protein Science

Volumn 8, Issue 10, 1999, Pages 2001-2009

  Westling, Jennifer ^a   Cipullo, Patty ^a   Hung, Su Hwi ^a   Saft, Howard ^a   Dame, John B ^b   Dunn, Ben M ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c NONE   (United States)

Author keywords

Active site; Aspartic protease; Hemoglobin degradation; Malaria; Mutagenesis; Oligopeptide substrates; Plasmepsin II

Indexed keywords

AMINO ACID; ASPARTIC PROTEINASE; CHROMOGENIC SUBSTRATE; OCTAPEPTIDE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; MUTAGENESIS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032880049     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.10.2001     Document Type: Article

References (32)

1. Abad-Zapatero C, Rydel TJ, Erickson J. 1990. Revised 2.3 D Structure of porcine pepsin: Evidence for a flexible subdomain. Proteins 8:62-81.
2. cat. Arch Biochem Biophys 306:297-303.
3. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder RC, Cachau RE, Collins J, Silva AM, Erickson JW. 1993. Crystal structures of native and inhibited forms of human cathepsin D: Implications for lysosomal targeting and drug design. Proc Natl Acad Sci USA 90:6796-6800.
4. Beyer BM, Dunn BM. 1996. Self-activation of recombinant human lysosomal procathepsin D at a newly engineered cleavage junction, "short" pseudocathepsin D. J Biol Chem 271:15590-15596.
5. Beyer B, Dunn BM. 1998. Prime region subsite specificity characterization of human cathepsin D: The dominant role of position 128. Protein Sci 7:88-95.
6. Dame JB, Reddy GR, Yowell CA, Dunn BM, Kay J, Berry C. 1994. Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 64:177-190.
7. Dunn BM, Scarborough PE, Davenport R, Swietnicki W. 1994. Analysis of proteinase specificity by studies of peptide substrates: The use of UV and fluorescence spectroscopy to quantitate rates of enzymatic cleavage. In: Dunn BM, Pennington MW, eds. Methods in molecular biology, Vol. 36: Peptide analysis protocols. Totowa, New Jersey: Humana Press Inc. pp 225-243.
8. Dunn BM, Scarborough PE, Lowther WT, Rao-Naik C. 1995. Comparison of the active site specificity of the aspartic proteinases based on a systematic series of peptide substrates In: Takahashi K, ed. Aspartic proteinases: Structure, function, biology and biomedical implications. New York: Plenum Press. pp 1-10.
9. Francis SE, Gluzman IY, Oksman A, Knickerbocker A, Mueller R, Bryant ML, Sherman DR, Russell DG, Goldberg DE. 1994. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J 13:306-317.
10. Gluzman IY, Francis SE, Oksman A, Smith CE, Duffin KL, Goldberg DE. 1994. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J Clin Invest 93:1602-1608.
11. Goldberg DE. 1998. Plasmepsin II. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of proteolytic enzymes. San Diego: Academic Press. pp 860-862.
12. Goldberg DE, Slater AF, Beavis R, Chait B, Cerami A, Henderson GB. 1991. Hemoglobin degradation in the human malaria pathogen Plasmodium falicparum: A catabolic pathway initiated by a specific aspartic protease. J Exp Med 173:961-919.
13. Henderson PJF. 1972. A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J 127:321-333.
14. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
15. James MNG, Sielecki AR, Hofmann T. 1985. X-ray diffraction studies on penicillopepsin and its complexes: The hydrolytic mechanism. In: Kostka V. ed. Aspartic proteinases and their inhihitors. Berlin: Walter de Gruyter. pp 163-177.
16. Leatherbarrow RJ, Fersht AR, Winter G. 1985. Transition-state stabilization in the mechanism of tyrosyl-tRNA synthetase revealed by protein engineering. Proc Natl Acad Sci USA 82:7840-7844.
17. Lowther WT, Chen Z, Lin X, Tang J, Dunn BM. 1992. Substrate specificity study of recombinant Rhizopus chinensis aspartic proteinase. In: Dunn BM, ed. The structure and function of the aspartic proteinases: Genetic, structures and mechanisms. New York: Plenum Press. pp 275-279.
18. Lowther WT, Majer P, Dunn BM. 1995. Engineering the substrate specificity of rhizopuspepsin: The role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in Pl. Protein Sci 4:689-702.
19. Marquardt DW. 1963. An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math 11:431-441.
20. Meyer SL. 1975. Data analysis for scientists and engineers. New York: John Wiley and Sons.
21. Pohl J, Dunn BM. 1988. Secondary enzyme-substrate interactions: Kinetic evidence for ionic interactions between substrate side chains and the pepsin active site. Biochemistry 27:4827-4834.
22. Powers JC, Harley AD, Meyers DV. 1977. Subsite specificity of porcine pepsin. In: Tang J, ed. Acid proteases: Structure, function and biology. New York: Plenum. pp 141-157.
23. Rao CM. 1994. A detailed investigation into the enzymatic specificity of porcine pepsin. Dissertation. Gainesville, Florida: University of Florida.
24. 2 subsite. Protein Eng 7:495-502.
25. Scarborough PE, Guruprasad K, Topham C, Richo GR, Conner GE, Blundell TL, Dunn BM. 1993. Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling. Protein Sci 2:264-276.
26. Schecter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27:157-162.
27. Shintani T, Ichishima E. 1994. Primary structure of aspergillopepsin 1 deduced from nucleotide sequence of the gene and aspartic acid-76 is an essential active site of the enzyme for trypsinogen activation. Biochim Biophys Acta 1204:257-264.
28. 1 substrate specificity of pepsin to those of fungal aspartic proteinases by site-directed mutagenesis. J Biol Chem 272:18855-18861.
29. Silva AM, Lee AY, Gulnik SV, Majer P, Collins J, Bhat TN, Collins PJ, Cachau RE, Luker KE, Gluzman IY, Francis SE, Oksman A, Goldberg DE, Erickson JW. 1996. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc Natl Acad Sci USA 93:10034-10039.
30. Suguna K, Padlan EA, Smith CD, Carlson WD, Davies DR. 1987. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: Implications for a mechanism of action. Proc Natl Acad Sci USA 84:7009-7013.
31. Taylor G, Hoare M, Gray DR, Marston FAO. 1986. Size and density of protein inclusion-bodies. Biotechnology 4:553-557.
32. World Health Organization. 1997. World malaria situation in 1994. Part I. Population at risk. Wkly Epidemiol Rec 72:269-274.